108 related articles for article (PubMed ID: 7328664)
21. [Immunoenzyme test system based on F(ab)2-antibody fragments for demonstrating influenza virus hemagglutinin].
Leonov SV; Zakomyrdin IuA; Eggert GI; Sokolova MV; Khristova ML
Vopr Virusol; 1987; 32(4):498-502. PubMed ID: 3318135
[No Abstract] [Full Text] [Related]
22. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.
Wan H; Yang H; Shore DA; Garten RJ; Couzens L; Gao J; Jiang L; Carney PJ; Villanueva J; Stevens J; Eichelberger MC
Nat Commun; 2015 Feb; 6():6114. PubMed ID: 25668439
[TBL] [Abstract][Full Text] [Related]
23. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
[TBL] [Abstract][Full Text] [Related]
24. Effect of monoclonal anti-neuraminidase antibodies on the kinetic behavior of influenza virus neuraminidase.
Mountford CE; Grossman G; Holmes KT; O'Sullivan WJ; Hampson AW; Raison RL; Webster R
Mol Immunol; 1982 Jun; 19(6):811-6. PubMed ID: 7110144
[TBL] [Abstract][Full Text] [Related]
25. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
[TBL] [Abstract][Full Text] [Related]
26. Anti-neuraminidase antibodies: which substrate should be used to test their effect on influenza virus neuraminidase.
Mountford CE; Holmes KT; Hampson AW
Biochem Biophys Res Commun; 1981 Nov; 103(2):469-74. PubMed ID: 6977358
[No Abstract] [Full Text] [Related]
27. Spot-scan imaging of microcrystals of an influenza neuraminidase-antibody fragment complex.
Bullough PA; Tulloch PA
Ultramicroscopy; 1991 Feb; 35(2):131-43. PubMed ID: 1866839
[TBL] [Abstract][Full Text] [Related]
28. Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5.
Lee JT; Air GM
Virology; 2006 Feb; 345(2):424-33. PubMed ID: 16297424
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies for characterizing H3N2 influenza viruses that persist in pigs in China.
Shortridge KF; King AP; Webster RG
J Infect Dis; 1987 Mar; 155(3):577-81. PubMed ID: 2433358
[No Abstract] [Full Text] [Related]
30. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional structures of influenza virus neuraminidase-antibody complexes.
Colman PM; Tulip WR; Varghese JN; Tulloch PA; Baker AT; Laver WG; Air GM; Webster RG
Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):511-8. PubMed ID: 2569208
[TBL] [Abstract][Full Text] [Related]
32. The complete neuraminidase of influenza A/PR8/34 (H0N1) is not detectable in its recombinant virus.
Arora DJ; Hill-Schubert J
Can J Microbiol; 1980 Nov; 26(11):1369-73. PubMed ID: 7214226
[TBL] [Abstract][Full Text] [Related]
33. [Immunoenzyme test system based on antibody F(ab)2-fragments for detecting the NP protein of the influenza virus].
Leonov SV; Khristova ML; Sokolova MV; Dönner L; Kharitonenkov IG
Vopr Virusol; 1988; 33(1):18-21. PubMed ID: 3285591
[TBL] [Abstract][Full Text] [Related]
34. Hybrid antibody-mediated lysis of virus-infected cells.
Staerz UD; Yewdell JW; Bevan MJ
Eur J Immunol; 1987 Apr; 17(4):571-4. PubMed ID: 3494618
[TBL] [Abstract][Full Text] [Related]
35. [Differentiation of equine influenza viruses subtype 2 with monoclonal antibodies].
Eichhorn W
Tierarztl Prax Suppl; 1987; 2():41-6. PubMed ID: 3590159
[TBL] [Abstract][Full Text] [Related]
36. [Determination of the antigenic specificity of the neuraminidase of influenza viruses].
Molibog EV; Selivanov IaM; Mel'nichenko EI; Isachenko VA; Zakstel'skaia LIa
Vopr Virusol; 1983; 28(1):46-50. PubMed ID: 6189296
[TBL] [Abstract][Full Text] [Related]
37. Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate.
Yoon SK; Mohr L; O'Riordan CR; Lachapelle A; Armentano D; Wands JR
Biochem Biophys Res Commun; 2000 Jun; 272(2):497-504. PubMed ID: 10833442
[TBL] [Abstract][Full Text] [Related]
38. Crystallization and preliminary X-ray diffraction studies of antigen--antibody complexes.
Chitarra-Guillon V; Souchon H; Boulot G; Riottot MM; Mariuzza R; Tello D; Poljak RJ
Biochimie; 1988 Aug; 70(8):1045-52. PubMed ID: 3147699
[TBL] [Abstract][Full Text] [Related]
39. [Differentiated study of specific antibody populations as a possible way to increase the prognostic value of indicators of humoral immunity in influenza].
Meringova LF; Iakovleva IV; Voĭtsekhovskiĭ BL; Dukhin AI; Poliak RIa
Vestn Akad Med Nauk SSSR; 1989; (11):75-80. PubMed ID: 2623938
[TBL] [Abstract][Full Text] [Related]
40. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
